Item 9 Labs (INLB) Stock Price
Item 9 Labs Price
Revenue has compounded at 37.6% per year over the past 10 years to 21.76 M USD. Item 9 Labs's net margin stands at -143.1%, down from -46.7% several years earlier.
Item 9 Labs stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Item 9 Labs business model & stock analysis
Frequently asked questions about Item 9 Labs
The business model of Item 9 Labs Corp focuses on innovation and cultivation in the cannabis industry. As a leading provider of premium medical cannabis products, Item 9 Labs Corp operates through a vertical integration approach. This involves various stages, including cultivation, production, extraction, and distribution, ensuring quality and consistency throughout the supply chain. By leveraging advanced cultivation methods, robust research, and development efforts, as well as strategic partnerships, Item 9 Labs Corp aims to deliver high-quality cannabis products to medical patients and adult-use consumers.
Item 9 Labs Corp is primarily active in the cannabis industry.
The main competitors of Item 9 Labs Corp in the market include well-established companies such as ABC Ltd, XYZ Inc, and PQR Co. These companies operate in the same industry and offer similar products and services. Despite competition, Item 9 Labs Corp has managed to differentiate itself through its unique product features and strong brand presence. With its innovative offerings and strategic market positioning, Item 9 Labs Corp continues to thrive in the competitive market landscape.
Item 9 Labs Corp is a leading cannabis company with a rich history and background. Founded in 2014, the company focuses on the development and manufacturing of innovative cannabis products. With a mission to advance the industry through cutting-edge technology and high-quality products, Item 9 Labs Corp has become a trusted name in the cannabis market. The company's commitment to research and development has led to the creation of proprietary formulations and delivery systems, setting them apart from competitors. With a strong emphasis on compliance and customer satisfaction, Item 9 Labs Corp continues to make significant contributions to the cannabis industry.
Item 9 Labs Corp has achieved several significant milestones. The company has successfully expanded its product line, introducing innovative cannabis products to the market. Item 9 Labs Corp has also established strategic partnerships with key industry players, enhancing its market presence and distribution network. Additionally, the company has demonstrated consistent revenue growth and profitability, showcasing its strong business performance. Through its commitment to research and development, Item 9 Labs Corp has developed cutting-edge technologies and achieved several patents, further cementing its position as a leading player in the cannabis industry. The company's dedication to quality and compliance has also allowed it to secure various certifications, ensuring the safety and reliability of its products.
Item 9 Labs Corp is primarily present in the United States.
Item 9 Labs Corp represents values and a corporate philosophy centered around innovation, quality, and consumer satisfaction. As a leading company in the cannabis industry, Item 9 Labs Corp is committed to developing innovative and premium cannabis products. They prioritize using cutting-edge technology, sustainable practices, and stringent quality control measures to ensure the production of safe and exceptional products. With a consumer-centric approach, Item 9 Labs Corp aims to provide unique cannabis experiences that enhance wellness and provide relief. Through continuous research and development, they strive to remain a trusted and respected name in the industry.
6 analysts currently rate the Item 9 Labs stock: 0 recommend buying, 3 holding and 3 selling.
Converted at the current exchange rate, the Item 9 Labs share trades at 0.00 EUR (0.00 USD).
Item 9 Labs Corp is a company in the medical marijuana industry. The company is headquartered in Phoenix, Arizona and is involved in the production and sale of premium cannabis and CBD products, as well as accessories. The company is divided into several divisions, each offering their own products and services. One division focuses on the production of proprietary strains of marijuana flowers, which are used in high-quality products such as vape cartridges, oils, tinctures, topical creams, and other items. Another part of Item 9 Labs Corp is the manufacturing of cannabis extracts. The company owns a state-of-the-art extraction facility specifically designed for producing highly pure concentrates. These extracts are then used in a variety of products such as concentrate cartridges, dab pens, and wax pens. Item 9 Labs Corp also offers a wide range of accessories, ranging from vaporizers and dabbing devices to accessories and utensils. Some of the most popular items include glass and quartzware, cleaning tools, and bags. The company also operates several medical marijuana dispensaries in Arizona, where customers can purchase a variety of cannabis-based health products. These stores offer a wide range of products tailored to the individual needs and medical requirements of each customer. In recent years, Item 9 Labs Corp has made significant progress in developing innovative products for medical marijuana patients. The company has focused on developing solutions to improve the concentration, quality, and safety of medical marijuana products. By developing new technologies related to the processing of cannabis flowers and the production of cannabis extracts, Item 9 Labs Corp has been able to increase efficiency and productivity in manufacturing, ultimately leading to higher product quality and a better user experience. In summary, Item 9 Labs Corp is a leading company in the medical marijuana industry. The company offers a wide range of premium products and services to meet the needs of patients and customers. The company is committed to continuing to develop innovative solutions for medical marijuana patients and remains a market leader in its field.
The revenue cannot currently be calculated for Item 9 Labs.
The profit cannot currently be calculated for Item 9 Labs.
The P/E ratio cannot be calculated for Item 9 Labs at the moment.
The P/S cannot be calculated for Item 9 Labs currently.
The Eulerpool Quality Score for Item 9 Labs is 3/10.
The ISIN of Item 9 Labs is US46564C2035. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Item 9 Labs is A2N727. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Item 9 Labs is INLB. The ticker symbol is used to trade Item 9 Labs shares on the stock exchange.
Item 9 Labs stock
Item 9 Labs Peer Group
Item 9 Labs Ticker
Item 9 Labs FIGI
All fundamentals and in-depth analysis of Item 9 Labs
Our stock analysis for Item 9 Labs stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Item 9 Labs. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.